title: Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
authors.affiliation: West China Hospital, Sichuan University, Chengdu, People's Republic of China.
authors.forename: Xiang
authors.initials: X
authors.lastname: Chen
authors.forename: Xianhuo
authors.initials: X
authors.lastname: Wang
authors.forename: Yongsheng
authors.initials: Y
authors.lastname: Wang
authors.forename: Li
authors.initials: L
authors.lastname: Yang
authors.forename: Jia
authors.initials: J
authors.lastname: Hu
authors.forename: Wenjing
authors.initials: W
authors.lastname: Xiao
authors.forename: Afu
authors.initials: A
authors.lastname: Fu
authors.forename: Lulu
authors.initials: L
authors.lastname: Cai
authors.forename: Xia
authors.initials: X
authors.lastname: Li
authors.forename: Xia
authors.initials: X
authors.lastname: Ye
authors.forename: Yalin
authors.initials: Y
authors.lastname: Liu
authors.forename: Wenshuang
authors.initials: W
authors.lastname: Wu
authors.forename: Ximing
authors.initials: X
authors.lastname: Shao
authors.forename: Yongqiu
authors.initials: Y
authors.lastname: Mao
authors.forename: Yuquan
authors.initials: Y
authors.lastname: Wei
authors.forename: Lijuan
authors.initials: L
authors.lastname: Chen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002412:Cations; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry*; D005434:Flow Cytometry; D020287:In Situ Nick-End Labeling; D007275:Injections, Intravenous; D008081:Liposomes; D008297:Male; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018625:Microscopy, Atomic Force; D009368:Neoplasm Transplantation; D017239:Paclitaxel / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D010316:Particle Size; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011485:Protein Binding; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism; D013499:Surface Properties
chemical_list: D000970:Antineoplastic Agents; D002412:Cations; D004337:Drug Carriers; D008081:Liposomes; D017468:Receptors, Fibroblast Growth Factor; D016222:Fibroblast Growth Factor 2; D004317:Doxorubicin; D017239:Paclitaxel